TOP 5 INSIGHTS IN CLINICAL SUPPLY CHAIN & LOGISTICS
OCTOBER EDITION
|
|
|
|
Genentech’s Clinical Supply Center, which opened in 2022 in South San Francisco, earned the company an ISPE Facility of the Year Award in the Pharma 4.0 category. This Q&A, the third in a series featuring FOYA winners, explores the strategy behind a central manufacturing site for clinical manufacturing.
|
|
|
|
By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.
|
|
|
|
There is a great opportunity for clinical supply chain practitioners to learn from their commercial peers. By adapting and adopting the right commercial best practices, clinical supply chains become more effective, cost-efficient, and agile in delivering the right treatments to the right patients.
|
|
|
|
Explore why handling development and manufacturing challenges for orphan drugs requires experience, expertise and scalable technologies, along with a flexible and agile supply chain.
|
|
|
|
FDA 21 CFR 211 requires vendor qualification as a part of the validation process and EU GxP requirements expect robust vendor management, and we expect regulators to issue firmer guidance sooner rather than later. Don't let your pharma/biotech fall short.
|
|
|